Facebook Twitter LinkedIn Instagram Email Printer Google Plus

COVID-19

Five Healthcare Predictions from Sam Glick and Terry Stone

2020 was a transformative year. Here's what might happen next with COVID-19, pharmacy cost, telehealth, and more.

Partner, Health and Life Sciences, Oliver Wyman
Managing Partner, Health and Life Sciences, and Global Chair for I&D, Oliver Wyman

Featured in the Middle East Insurance Review

COVID-19 sparked health system disruption in the Middle East. Here are some emerging digital health trends and mid-term insurer implications.

Partner, Health and Life Sciences, Oliver Wyman

Future Truths: Inevitable and Inspiring

Harnessing genomics will transform our daily lives, disrupt payer, provider, and pharma business models, and create new markets for next-generation prevention.

Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Principal, Oliver Wyman
Associate, Health and Life Sciences, Oliver Wyman

Timeline to Normalcy - Updated January 25, 2021

The journey to normalcy involves understanding and addressing many different factors. Our latest analysis suggests we are likely to achieve pHIT in the US on average in late summer.

Partner and Vice Chairman, Financial Services, Americas, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner and CMO, Health and Life Sciences, Oliver Wyman
Managing Partner, Health and Life Sciences, and Global Chair for I&D, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman

Why closing the loop and creating a virtuous health promotion cycle will transform "sick care" to "well-care."

Partner, Health and Life Sciences, Oliver Wyman
Associate, Oliver Wyman

Insights in your inbox

Subscribe

Strategies to be a leader who people trust and turn to for guidance and support in tough times.

Overheard at the 2021 J.P. Morgan Healthcare Conference

The future of care delivery is changing quickly, as are new focuses for executives driving big change ahead.

While many partnerships fail to deliver real economic value, here's how one CEO broke through.

CEO, UW Health
Partner, Health and Life Sciences, Oliver Wyman

Hospitals nationwide could near collapse as the pandemic straps them of necessary resources.

Partner & Co-Head – Risk & Public Policy, Americas, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

Six Predictions for an Industry in Transformation

Welltok and Oliver Wyman discuss why this year is healthcare's watershed moment and what may unfold in 2021.

Chairman of the Board, Welltok
Partner, Health and Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe